Clinical trial
A Study in Participants With Type 2 Diabetes Mellitus
NCT01468987
Study timeline
Study start (unknown)2011-12-01Date precision: month
Registry last updated2018-04-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
LY2605541DRUG
Insulin GlargineDRUG · verified · RxNorm: insulin glargine
Insulin LisproDRUG · verified · RxNorm: insulin lispro
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
SevilleSpain2New YorkNew York, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1BarcelonaSpain1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1BerlinGermany1JacksonvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01468987 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.